Human IL-23 antigen binding proteins
US12012449B2 · kind B2 · utility
0Cited by
82References
1Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 12, 2021 |
| Grant date | Jun 18, 2024 |
| Priority date | — |
| Expiry date | Jan 3, 2043 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/92
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Antigen binding proteins that bind to human IL-23 protein are provided. Nucleic acids encoding the antigen binding protein, vectors, and cells encoding the same as well as use of IL-23 antigen binding proteins for diagnostic and therapeutic purposes are also provided.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.